| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |